Cornelia F Allaart Selected Research

Cornelia F Allaart Research Topics

Disease

54	Rheumatoid Arthritis 04/2022 - 04/2006
13	Arthritis (Polyarthritis) 01/2021 - 05/2007
4	Inflammation (Inflammations) 04/2022 - 03/2013
3	Osteoarthritis 01/2022 - 11/2018
3	Pain (Aches) 01/2022 - 02/2014
3	Necrosis 07/2016 - 05/2009
2	Synovitis 01/2022 - 11/2019
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 12/2018
1	COVID-19 06/2022
1	Breakthrough Infections 06/2022
1	AIDS-Related Complex (ARC) 06/2022
1	digital ulcers 04/2022
1	Systemic Scleroderma (Systemic Sclerosis) 04/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Fatigue 06/2021
1	Osteoporosis 01/2021
1	Overweight 01/2020
1	Erythema 11/2019
1	Lyme Disease (Disease, Lyme) 11/2019
1	Myocardial Infarction 11/2019
1	Myoma 11/2019
1	Atrial Fibrillation 11/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017
1	Nasopharyngitis 07/2016
1	Rheumatic Diseases (Rheumatism) 07/2013
1	Drug-Related Side Effects and Adverse Reactions 04/2006
1	Pneumonia (Pneumonitis) 04/2006
1	Rheumatoid Vasculitis 08/2005

Drug/Important Bio-Agent (IBA)

21	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 04/2006
10	amsonic acid (DAS)IBA 01/2022 - 10/2007
10	Antirheumatic Agents (DMARD)IBA 12/2019 - 03/2007
9	Prednisone (Sone)FDA LinkGeneric 01/2022 - 05/2009
7	Pharmaceutical PreparationsIBA 11/2019 - 05/2011
5	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 03/2013
4	GlucocorticoidsIBA 01/2022 - 03/2013
4	AutoantibodiesIBA 01/2021 - 09/2014
4	Biological ProductsIBA 01/2019 - 03/2013
4	Tumor Necrosis Factor InhibitorsIBA 11/2018 - 03/2013
3	AntibodiesIBA 06/2022 - 01/2018
3	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 02/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 08/2005
2	acetyl 4-aminosalicylic acidIBA 01/2022 - 01/2021
2	Infliximab (Remicade)FDA Link 01/2020 - 08/2005
2	Etanercept (Enbrel)FDA Link 01/2020 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2013
2	Rheumatoid FactorIBA 01/2019 - 12/2015
2	ametantrone (HAQ)IBA 01/2019 - 10/2013
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2014
2	3-benzoyl dopamine (MBDA)IBA 11/2014 - 07/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2022
1	AntigensIBA 06/2022
1	SilverIBA 04/2022
1	Immunoglobulin A (IgA)IBA 04/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2019
1	boldenone undecylenate (Equipoise)IBA 12/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2018
1	Adalimumab (Humira)FDA Link 07/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	tocilizumab (atlizumab)FDA Link 07/2016
1	CitrullineIBA 10/2015
1	AllergensIBA 10/2015
1	EpitopesIBA 10/2015
1	Peptides (Polypeptides)IBA 10/2015
1	Protein Isoforms (Isoforms)IBA 04/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014
1	TNF Receptor-Associated Factor 1IBA 09/2007
1	Adenosine (Adenocard)FDA LinkGeneric 09/2006
1	EnzymesIBA 04/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2006

Therapy/Procedure

21	Therapeutics 01/2022 - 08/2005
3	Remission Induction 01/2018 - 09/2012
1	Hysterectomy 11/2019
1	Aftercare (After-Treatment) 08/2016
1	Intra-Articular Injections 02/2014
1	Injections 02/2014
1	Biological Therapy 03/2013
1	Retreatment 05/2011